Home » Topics » Regulatory » Patents

Patents
RSS

New CCR2 receptor antagonists presented by Merck & Co.

Oct. 16, 2012

Grindeks discloses single enantiomer for cognitive disorders

Oct. 16, 2012

Eternity Bioscience patents novel PARP-1 inhibitors

Oct. 16, 2012

Chinese researchers disclose new PAF acetylhydrolase inhibitors

Oct. 16, 2012

Probiodrug discloses novel glutaminyl cyclase inhibitors

Oct. 16, 2012

Novel tyrosine-protein kinase SYK inhibitors patented by GlaxoSmithKline

Oct. 15, 2012

Novel GPR119 receptor agonists prepared by Boehringer Ingelheim and Neurocrine Biosciences

Oct. 15, 2012

German researchers disclose novel tubulin polymerization inhibitors

Oct. 15, 2012

Novel glucocorticoid receptor ligands patented by Chiesi

Oct. 15, 2012

Roche synthesizes new HSL inhibitors

Oct. 15, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026